{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:08:23Z","timestamp":1783008503861,"version":"3.54.5"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Pediatric and Adolescent Health Care"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cppeds.2025.101732","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T06:56:51Z","timestamp":1743922611000},"page":"101732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Emerging therapeutics in the management of food allergy"],"prefix":"10.1016","volume":"55","author":[{"given":"Noor","family":"Hamideh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia Su Yin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cppeds.2025.101732_bib0001","article-title":"The public health impact of parent-reported childhood food allergies in the United States. 2018:142(6):e20181235","volume":"143","author":"Gupta","year":"2019","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.cppeds.2025.101732_bib0002","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4168\/aair.2018.10.3.189","article-title":"Allergen-specific immunotherapies for food allergy","volume":"10","author":"Feuille","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.cppeds.2025.101732_bib0003","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2014.08.006","article-title":"Modulation of dendritic cell innate and adaptive immune functions by oral and sublingual immunotherapy","volume":"155","author":"Frischmeyer-Guerrerio","year":"2014","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.cppeds.2025.101732_bib0004","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","article-title":"Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective","volume":"139","author":"Vickery","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.cppeds.2025.101732_bib0005","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jaci.2015.12.1316","article-title":"Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy","volume":"137","author":"Jones","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"10187","key":"10.1016\/j.cppeds.2025.101732_bib0006","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.cppeds.2025.101732_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12268","article-title":"Efficacy and safety of oral immunotherapy for peanut, cow's milk, and hen's egg allergy: a systematic review of randomized controlled trials","volume":"13","author":"Lodge","year":"2023","journal-title":"Clin Transl Allergy"},{"issue":"4","key":"10.1016\/j.cppeds.2025.101732_bib0008","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/all.13319","article-title":"EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy","volume":"73","author":"Pajno","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.cppeds.2025.101732_bib0009","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13223-020-0413-7","article-title":"CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy","volume":"16","author":"B\u00e9gin","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"10.1016\/j.cppeds.2025.101732_bib0010","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.alit.2020.03.004","article-title":"Committee for Japanese pediatric guideline for food allergy, the Japanese society of pediatric allergy and clinical immunology, Japanese Society of Allergology. Japanese guidelines for food allergy 2020","volume":"69","author":"Ebisawa","year":"2020","journal-title":"Allergol Int"},{"issue":"5","key":"10.1016\/j.cppeds.2025.101732_bib0011","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jaci.2014.05.013","article-title":"Food allergy: a practice parameter update-2014","volume":"134","author":"Sampson","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.cppeds.2025.101732_bib0012","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.jaci.2024.02.019","article-title":"Preparing patients for oral immunotherapy (PPOINT): international Delphi consensus for procedural preparation and consent","volume":"153","author":"Mack","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"10322","key":"10.1016\/j.cppeds.2025.101732_bib0013","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cppeds.2025.101732_bib0014","unstructured":"Food allergy [Internet]. [cited 2024 Sep 5]. Available from: https:\/\/www.nace.org.au\/research\/food-allergy\/."},{"issue":"1","key":"10.1016\/j.cppeds.2025.101732_bib0015","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41598-019-56961-3","article-title":"Adverse events associated with peanut oral immunotherapy in children - a systematic review and meta-analysis","volume":"10","author":"Grzeskowiak","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.cppeds.2025.101732_bib0016","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.jaip.2019.04.010","article-title":"First real-world safety analysis of preschool peanut oral immunotherapy","volume":"7","author":"Soller","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.cppeds.2025.101732_bib0017","first-page":"20","article-title":"Peanut allergen powder (Palforzia) for Peanut allergy","volume":"105","author":"Erlich","year":"2022","journal-title":"Am Fam Physician"},{"issue":"21","key":"10.1016\/j.cppeds.2025.101732_bib0018","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 Oral immunotherapy for peanut allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.cppeds.2025.101732_bib0019","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2352-4642(20)30234-0","article-title":"Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial","volume":"4","author":"O'B Hourihane","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.cppeds.2025.101732_bib0020","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2312382","article-title":"Omalizumab for the treatment of multiple food allergies","author":"Wood","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.cppeds.2025.101732_bib0021","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2011.01.051","article-title":"A phase II, randomized, double\u2011blind, parallel\u2011group, placebo\u2011controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy","volume":"127","author":"Sampson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.cppeds.2025.101732_bib0022","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S2468-1253(17)30392-8","article-title":"Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial","volume":"3","author":"Andorf","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cppeds.2025.101732_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.10.005","article-title":"A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy","volume":"137","author":"Wood","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.cppeds.2025.101732_bib0024","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaci.2016.08.010","article-title":"Omalizumab facilitates rapid oral desensitization for peanut allergy","volume":"139","author":"MacGinnitie","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.cppeds.2025.101732_bib0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.anai.2017.06.001","article-title":"Factors associated with epinephrine administration for anaphylaxis in children before arrival to the emergency department","volume":"119","author":"Robinson","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.cppeds.2025.101732_bib0026","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jaci.2023.08.007","article-title":"Pharmacokinetics\/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection","volume":"152","author":"Casale","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.cppeds.2025.101732_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16060811","article-title":"Development of, an epinephrine nasal spray, for severe allergic reactions","volume":"16","author":"Ellis","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cppeds.2025.101732_bib0028","unstructured":"ClinicalTrials.Gov [Internet]. [cited 2024 Aug 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04056299."},{"issue":"2","key":"10.1016\/j.cppeds.2025.101732_bib0029","doi-asserted-by":"crossref","first-page":"AB240","DOI":"10.1016\/j.jaci.2023.11.772","article-title":"Treatment of single and multiple food allergies with ADP101: results of the harmony phase 1\/2 trial","volume":"153","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.cppeds.2025.101732_bib0030","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/jama.2019.1113","article-title":"Effect of Epicutaneous Immunotherapy vs Placebo on reaction to peanut protein ingestion among children with peanut allergy: the PEPITES randomized clinical trial","volume":"321","author":"Fleischer","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.cppeds.2025.101732_bib0031","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaci.2020.06.028","article-title":"Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results","volume":"146","author":"Fleischer","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.cppeds.2025.101732_bib0032","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.jaip.2021.11.017","article-title":"Safety of epicutaneous immunotherapy in peanut-allergic children: REALISE randomized clinical trial results","volume":"10","author":"Pongracic","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"19","key":"10.1016\/j.cppeds.2025.101732_bib0033","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1056\/NEJMoa2212895","article-title":"Phase 3 trial of epicutaneous immunotherapy in toddlers with peanut allergy","volume":"388","author":"Greenhawt","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cppeds.2025.101732_bib0034","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamapediatrics.2023.6630","article-title":"Varying doses of epicutaneous immunotherapy with Viaskin milk vs Placebo in children with cow's milk allergy: a randomized clinical trial","volume":"178","author":"Petroni","year":"2024","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.cppeds.2025.101732_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/0091-6749(92)90080-L","article-title":"Treatment of peanut allergy with rush immunotherapy","volume":"90","author":"Oppenheimer","year":"1992","journal-title":"J Allergy Clin Immunol"},{"issue":"6 Pt 1","key":"10.1016\/j.cppeds.2025.101732_bib0036","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0091-6749(97)80006-1","article-title":"Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract","volume":"99","author":"Nelson","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cppeds.2025.101732_bib0037","unstructured":"ClinicalTrials.gov [Internet]. [cited 2024 Nov 12]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02991885."},{"issue":"2","key":"10.1016\/j.cppeds.2025.101732_bib0038","doi-asserted-by":"crossref","first-page":"AB243","DOI":"10.1016\/j.jaci.2018.12.744","article-title":"Development of a subcutaneous immunotherapy (SCIT) with a modified peanut extract formulation for the treatment of peanut allergy","volume":"143","author":"Larionov","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cppeds.2025.101732_bib0039","unstructured":"ClinicalTrials.gov [Internet]. [cited 2024 Oct 18]. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT05440643."},{"issue":"1","key":"10.1016\/j.cppeds.2025.101732_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2023.08.032","article-title":"Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: a randomized, placebo-controlled trial","volume":"153","author":"Kim","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.cppeds.2025.101732_bib0041","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2012.11.011","article-title":"Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial","volume":"131","author":"Fleischer","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cppeds.2025.101732_bib0042","unstructured":"ClinicalTrials.gov [Internet]. [cited 2024 Aug 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04603300."},{"issue":"2","key":"10.1016\/j.cppeds.2025.101732_bib0043","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/all.15966","article-title":"Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy","volume":"79","author":"Voskamp","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.cppeds.2025.101732_bib0044","unstructured":"ClinicalTrials.gov [Internet]. [cited 2024 Aug 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05621317."},{"issue":"2","key":"10.1016\/j.cppeds.2025.101732_bib0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/all.15931","article-title":"Safety and immunopharmacology of ASP0892 in adults or adolescents with peanut allergy: two randomized trials","volume":"79","author":"Ferslew","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.cppeds.2025.101732_bib0046","unstructured":"ClinicalTrials.gov [Internet]. [cited 2024 Aug 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03679676."},{"key":"10.1016\/j.cppeds.2025.101732_bib0047","unstructured":"ClinicalTrials.gov [Internet]. [cited 2024 Aug 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03682770."},{"key":"10.1016\/j.cppeds.2025.101732_bib0048","unstructured":"ClinicalTrials.gov [Internet]. [cited 2024 Aug 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04148352."},{"key":"10.1016\/j.cppeds.2025.101732_bib0049","unstructured":"ClinicalTrials.gov [Internet]. [cited 2024 Aug 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03793608."},{"issue":"17","key":"10.1016\/j.cppeds.2025.101732_bib0050","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","article-title":"Anti-Siglec-8 antibody for eosinophilic gastritis and duodenitis","volume":"383","author":"Dellon","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cppeds.2025.101732_bib0051","unstructured":"ClinicalTrials.gov [Internet]. [cited 2024 Aug 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05069831."},{"key":"10.1016\/j.cppeds.2025.101732_bib0052","unstructured":"ClinicalTrials.gov [Internet]. [cited 2024 Aug 20]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04872218."},{"issue":"3","key":"10.1016\/j.cppeds.2025.101732_bib0053","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2014.11.034","article-title":"Administration of a probiotic with peanut oral immunotherapy: a randomized trial","volume":"135","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.cppeds.2025.101732_bib0054","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2352-4642(22)00006-2","article-title":"Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial","volume":"6","author":"Loke","year":"2022","journal-title":"Lancet Child Adolesc Health"}],"container-title":["Current Problems in Pediatric and Adolescent Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538544225000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538544225000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:28:40Z","timestamp":1749144520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538544225000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1538544225000069"],"URL":"https:\/\/doi.org\/10.1016\/j.cppeds.2025.101732","relation":{},"ISSN":["1538-5442"],"issn-type":[{"value":"1538-5442","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging therapeutics in the management of food allergy","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Pediatric and Adolescent Health Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cppeds.2025.101732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101732"}}